References
- Bohan T. P., Helton E., MacDonald I., Konig S., Gazitt S., Sugimoto T., Scheffner D., Cusmano L., Li S., Koch G. Effect of L‐carnitine treatment for valproate‐induced hepatotoxicity. Neurology 2001; 56: 1405–1409
- Beauchamp J., Olson K. Valproic acid overdoses: a retrospective study comparing serum drug levels and the incidence of adverse outcomes. J Toxicol Clin Toxicol 1999; 37: 637–638
- Amato A., Sigma Tau Pharmaceuticals Letter, 7/23/1998
- Carnitor®. Physicians' Desk Reference56th ed. Medical Economics Company, Montvale, NJ 2002; 3242–3245, Anon
- Vossler D. G., Wilensky A. J., Cawthon D. F., Kraemer D. L., Ojemann L. M., Caylor L. M., Morgan J. D. Serum and CSF glutamine levels in valproate‐related hyperammonemic encephalopathy. Epilepsia 2002; 43: 154–159
- Murakami K., Sugimoto T., Woo M., Nishida N., Muro H. Effect of L‐carnitine supplementation on acute valproate intoxication. Epilepsia 1996; 37: 687–689
- Ishikura H., Matsuo N., Matsubara M., Ishihara T., Takeyama N., Tanaka T. Valproic acid overdose and L‐carnitine therapy. J Anal Toxicol 1996; 20: 55–58
- Murphy J. V., Marquardt K. V. Asymptomatic hyperammonemia in patients receiving valproate. Arch Neurol 1982; 39: 591–592